
Jennifer Castriotta
Examiner (ID: 2648, Phone: (571)270-5279 , Office: P/3781 )
| Most Active Art Unit | 3733 |
| Art Unit(s) | 3781, 3733 |
| Total Applications | 769 |
| Issued Applications | 457 |
| Pending Applications | 68 |
| Abandoned Applications | 260 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11657512
[patent_doc_number] => 09670504
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-06
[patent_title] => 'Transgenic system for reversibly immortalizing mammalian quiescent cells'
[patent_app_type] => utility
[patent_app_number] => 14/124184
[patent_app_country] => US
[patent_app_date] => 2012-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9181
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14124184
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/124184 | Transgenic system for reversibly immortalizing mammalian quiescent cells | Jul 5, 2012 | Issued |
Array
(
[id] => 9254464
[patent_doc_number] => 08617876
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-31
[patent_title] => 'Rhodopsin gene conserved regions in a viral vector enhance expression'
[patent_app_type] => utility
[patent_app_number] => 13/539835
[patent_app_country] => US
[patent_app_date] => 2012-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 21
[patent_no_of_words] => 36258
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 254
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13539835
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/539835 | Rhodopsin gene conserved regions in a viral vector enhance expression | Jul 1, 2012 | Issued |
Array
(
[id] => 16406742
[patent_doc_number] => 10815285
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-27
[patent_title] => Recombinant adeno-associated virus-mediated expression of fractalkine for treatment of neuroinflammatory and neurodegenerative diseases
[patent_app_type] => utility
[patent_app_number] => 14/126708
[patent_app_country] => US
[patent_app_date] => 2012-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14958
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14126708
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/126708 | Recombinant adeno-associated virus-mediated expression of fractalkine for treatment of neuroinflammatory and neurodegenerative diseases | Jun 29, 2012 | Issued |
Array
(
[id] => 8516818
[patent_doc_number] => 20120316226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-13
[patent_title] => 'METHODS OF GENE THERAPY FOR TREATING DISORDERS OF THE EAR BY ADMINISTERING A VECTOR ENCODING AN ATONAL-ASSOCIATED FACTOR'
[patent_app_type] => utility
[patent_app_number] => 13/533322
[patent_app_country] => US
[patent_app_date] => 2012-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17552
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13533322
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/533322 | METHODS OF GENE THERAPY FOR TREATING DISORDERS OF THE EAR BY ADMINISTERING A VECTOR ENCODING AN ATONAL-ASSOCIATED FACTOR | Jun 25, 2012 | Abandoned |
Array
(
[id] => 8502554
[patent_doc_number] => 20120301962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-29
[patent_title] => 'VITRONECTIN-DERIVED CELL CULTURE SUBSTRATE AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/464235
[patent_app_country] => US
[patent_app_date] => 2012-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6444
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13464235
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/464235 | Vitronectin-derived cell culture substrate and uses thereof | May 3, 2012 | Issued |
Array
(
[id] => 9308896
[patent_doc_number] => 20140047570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'ANIMAL MODEL OF HUMAN CANCER AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 14/113014
[patent_app_country] => US
[patent_app_date] => 2012-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15454
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113014
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/113014 | ANIMAL MODEL OF HUMAN CANCER AND METHODS OF USE | Apr 18, 2012 | Abandoned |
Array
(
[id] => 8768333
[patent_doc_number] => 20130096370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'COMPOSITIONS AND SYSTEMS FOR THE REGULATION OF GENES'
[patent_app_type] => utility
[patent_app_number] => 13/448580
[patent_app_country] => US
[patent_app_date] => 2012-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 32232
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13448580
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/448580 | COMPOSITIONS AND SYSTEMS FOR THE REGULATION OF GENES | Apr 16, 2012 | Abandoned |
Array
(
[id] => 9148370
[patent_doc_number] => 20130302893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'METHOD FOR INCREASING THE EFFICIENCY OF INDUCING PLURIPOTENT STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/808596
[patent_app_country] => US
[patent_app_date] => 2012-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8283
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808596
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/808596 | Method for increasing the efficiency of inducing pluripotent stem cells | Mar 30, 2012 | Issued |
Array
(
[id] => 9297430
[patent_doc_number] => 20140041064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => 'COMPOSITIONS AND METHODS FOR IDENTIFYING VIRULENCE FACTORS AND ANTI-FUNGAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/003349
[patent_app_country] => US
[patent_app_date] => 2012-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17406
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14003349
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/003349 | COMPOSITIONS AND METHODS FOR IDENTIFYING VIRULENCE FACTORS AND ANTI-FUNGAL AGENTS | Mar 6, 2012 | Abandoned |
Array
(
[id] => 9421744
[patent_doc_number] => 20140106395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-17
[patent_title] => 'Hanging Droplet Plate'
[patent_app_type] => utility
[patent_app_number] => 14/002269
[patent_app_country] => US
[patent_app_date] => 2012-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 6071
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14002269
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/002269 | Hanging droplet plate | Mar 1, 2012 | Issued |
Array
(
[id] => 9286505
[patent_doc_number] => 08642835
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-04
[patent_title] => 'ADAM6 mice'
[patent_app_type] => utility
[patent_app_number] => 13/404075
[patent_app_country] => US
[patent_app_date] => 2012-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 46923
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13404075
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/404075 | ADAM6 mice | Feb 23, 2012 | Issued |
Array
(
[id] => 12946234
[patent_doc_number] => 09834788
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-05
[patent_title] => AAV -vectors for use in gene therapy of choroideremia
[patent_app_type] => utility
[patent_app_number] => 14/000836
[patent_app_country] => US
[patent_app_date] => 2012-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 8378
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14000836
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/000836 | AAV -vectors for use in gene therapy of choroideremia | Feb 20, 2012 | Issued |
Array
(
[id] => 9175108
[patent_doc_number] => 20130317093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'METHODS OF TREATING ALZHEIMER\'S DISEASE WITH APO A-1 MILANO'
[patent_app_type] => utility
[patent_app_number] => 13/983956
[patent_app_country] => US
[patent_app_date] => 2012-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9964
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13983956
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/983956 | METHODS OF TREATING ALZHEIMER'S DISEASE WITH APO A-1 MILANO | Feb 8, 2012 | Abandoned |
Array
(
[id] => 8212309
[patent_doc_number] => 20120130303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'RATE CONTROL DURING AF USING CELLULAR INTERVENTION TO MODULATE AV NODE'
[patent_app_type] => utility
[patent_app_number] => 13/359949
[patent_app_country] => US
[patent_app_date] => 2012-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 4268
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20120130303.pdf
[firstpage_image] =>[orig_patent_app_number] => 13359949
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/359949 | RATE CONTROL DURING AF USING CELLULAR INTERVENTION TO MODULATE AV NODE | Jan 26, 2012 | Abandoned |
Array
(
[id] => 9280224
[patent_doc_number] => 20140030192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-30
[patent_title] => 'Functional Targeted Brain Endoskeletonization'
[patent_app_type] => utility
[patent_app_number] => 13/980842
[patent_app_country] => US
[patent_app_date] => 2012-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7846
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13980842
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/980842 | Functional Targeted Brain Endoskeletonization | Jan 25, 2012 | Abandoned |
Array
(
[id] => 10143256
[patent_doc_number] => 09176063
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-03
[patent_title] => 'Modified fluorescent protein'
[patent_app_type] => utility
[patent_app_number] => 13/884520
[patent_app_country] => US
[patent_app_date] => 2011-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 18
[patent_no_of_words] => 5277
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884520
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/884520 | Modified fluorescent protein | Nov 9, 2011 | Issued |
Array
(
[id] => 12485139
[patent_doc_number] => 09992981
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Optogenetic control of reward-related behaviors
[patent_app_type] => utility
[patent_app_number] => 13/882670
[patent_app_country] => US
[patent_app_date] => 2011-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 48
[patent_no_of_words] => 24249
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13882670
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/882670 | Optogenetic control of reward-related behaviors | Nov 3, 2011 | Issued |
Array
(
[id] => 9265208
[patent_doc_number] => 20130347137
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-26
[patent_title] => 'Stabilized Step Function Opsin Proteins and Methods of Using the Same'
[patent_app_type] => utility
[patent_app_number] => 13/882666
[patent_app_country] => US
[patent_app_date] => 2011-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 32188
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13882666
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/882666 | Stabilized step function opsin proteins and methods of using the same | Nov 3, 2011 | Issued |
Array
(
[id] => 8210017
[patent_doc_number] => 20120129224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'Method and apparatus for changing one type of cell into another type of cell'
[patent_app_type] => utility
[patent_app_number] => 13/288801
[patent_app_country] => US
[patent_app_date] => 2011-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10237
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20120129224.pdf
[firstpage_image] =>[orig_patent_app_number] => 13288801
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/288801 | Method and apparatus for changing one type of cell into another type of cell | Nov 2, 2011 | Abandoned |
Array
(
[id] => 8177213
[patent_doc_number] => 20120110683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-03
[patent_title] => 'NON-HUMAN ANIMAL MODEL OF MYOCARDIAL INFARCTION AND METHOD FOR CREATING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/288158
[patent_app_country] => US
[patent_app_date] => 2011-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9908
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20120110683.pdf
[firstpage_image] =>[orig_patent_app_number] => 13288158
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/288158 | NON-HUMAN ANIMAL MODEL OF MYOCARDIAL INFARCTION AND METHOD FOR CREATING THE SAME | Nov 2, 2011 | Abandoned |